Donya Salahaldin

Donya Salahaldin is a Quality Assurance Specialist at Novo Nordisk with a background in pharmacy, pharmacology, and pharmaceutical technology. Starting as a Farmakonom at Axeltorvsapotek, Donya has held various positions in the pharmaceutical industry, including roles at Hedensted apotek and Borup apotek. Donya's academic journey began at Fredericia gymnasium and continued at Syddansk Universitet, where Donya obtained a Cand.pharm degree. Donya's research includes studying the effects of food restriction and GLP-1/Glucagon receptor co-agonist treatment on weight loss in rats.